Institutional Ownership Gain Therapeutics, Inc. (GANX)
This table provides information about the institutional ownership of Gain Therapeutics, Inc. (GANX). We have compiled data on the 39 institutions that hold shares in the stock, with a total of 4.47 Million shares, which have been reported (via 13F filing form) to have a value of $6.84 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Jones Financial Companies Lllp
|
Aug 13, 2025 Q2 2025 |
676,888
shares
|
$1.04 Million
0.0% of portfolio
|
Q2 2025
Added 58.26%
|
|
|
David Einhorn
Greenlight Capital Inc | New York, Ny
|
Feb 14, 2024 Q4 2023 |
588,410
shares
|
$900,267
0.1% of portfolio
|
Q4 2023
Added 7.66%
|
|
|
Dme Capital Management, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
566,130
shares
|
$866,178
0.04% of portfolio
|
Q1 2024
New holding
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
534,352
shares
|
$817,558
0.0% of portfolio
|
Q2 2025
Added 109.56%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
290,462
shares
|
$444,406
0.0% of portfolio
|
Q2 2025
Added 2.92%
|
|
|
Marshall Wace, LLP
London, X0 |
Aug 13, 2025 Q2 2025 |
276,433
shares
|
$422,942
0.0% of portfolio
|
Q2 2025
Added 41.02%
|
|
|
Joel Greenblatt
Gotham Asset Management, LLC | New York, Ny
|
Aug 14, 2025 Q2 2025 |
245,896
shares
|
$376,220
0.0% of portfolio
|
Q2 2025
Added 59.69%
|
|
|
Cambridge Investment Research Advisors, Inc.
|
Jul 31, 2025 Q2 2025 |
179,500
shares
|
$274,635
0.0% of portfolio
|
Q2 2025
Added 201.68%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
161,816
shares
|
$247,578
0.0% of portfolio
|
Q2 2025
Added 750.81%
|
|
|
Telemetry Investments, L.L.C.
New York, NY |
Feb 14, 2023 Q4 2022 |
123,000
shares
|
$188,190
0.61% of portfolio
|
Q4 2022
Reduced 18.0%
|
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
100,170
shares
|
$153,260
0.0% of portfolio
|
Q1 2025
Added 18.42%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
94,000
shares
|
$143,820
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
84,620
shares
|
$129,468
0.0% of portfolio
|
Q2 2024
Added 12.23%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Aug 14, 2025 Q2 2025 |
79,551
shares
|
$121,713
0.0% of portfolio
|
Q2 2025
Reduced 7.45%
|
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
76,512
shares
|
$117,063
0.0% of portfolio
|
Q2 2025
Reduced 23.33%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
71,137
shares
|
$108,839
0.0% of portfolio
|
Q4 2024
Added 106.57%
|
|
|
Kovitz Investment Group Partners, LLC
|
Aug 14, 2025 Q2 2025 |
47,578
shares
|
$72,794
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Dauntless Investment Group, LLC
Commerce Township, MI |
Aug 14, 2025 Q2 2025 |
46,000
shares
|
$70,380
0.15% of portfolio
|
Q2 2025
Reduced 63.37%
|
|
|
Prelude Capital Management, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
35,820
shares
|
$54,804
0.01% of portfolio
|
Q1 2024
Reduced 38.35%
|
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
32,635
shares
|
$49,931
0.0% of portfolio
|
Q2 2025
Reduced 24.73%
|
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Aug 14, 2025 Q2 2025 |
30,004
shares
|
$45,906
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Virtu Financial LLC
New York, NY |
Aug 12, 2025 Q2 2025 |
23,801
shares
|
$36,415
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Benedict Financial Advisors Inc
|
Aug 13, 2025 Q2 2025 |
22,500
shares
|
$34,425
0.01% of portfolio
|
Q2 2025
Added 25.0%
|
|
|
Sandhill Capital Partners LLC
Buffalo, NY |
May 14, 2025 Q1 2025 |
15,400
shares
|
$23,562
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Gsa Capital Partners LLP
London, X0 |
Jul 22, 2025 Q2 2025 |
12,756
shares
|
$19,516
0.0% of portfolio
|
Q2 2025
New holding
|